AlzChem Group AG

XTRA:ACT 株式レポート

時価総額:€492.5m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

AlzChem Group 将来の成長

Future 基準チェック /26

AlzChem Group利益と収益がそれぞれ年間9.4%と4.8%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に21.2% 9.4%なると予測されています。

主要情報

9.4%

収益成長率

9.4%

EPS成長率

Chemicals 収益成長36.4%
収益成長率4.8%
将来の株主資本利益率21.2%
アナリストカバレッジ

Low

最終更新日13 Jun 2024

今後の成長に関する最新情報

Recent updates

A Look At The Intrinsic Value Of AlzChem Group AG (ETR:ACT)

Jun 04
A Look At The Intrinsic Value Of AlzChem Group AG (ETR:ACT)

AlzChem Group's (ETR:ACT) Earnings Seem To Be Promising

May 08
AlzChem Group's (ETR:ACT) Earnings Seem To Be Promising

Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being

May 01
Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being

AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's

Apr 26
AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's

Is AlzChem Group (ETR:ACT) A Risky Investment?

Apr 11
Is AlzChem Group (ETR:ACT) A Risky Investment?

AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20

Mar 29
AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20

The Market Lifts AlzChem Group AG (ETR:ACT) Shares 26% But It Can Do More

Mar 07
The Market Lifts AlzChem Group AG (ETR:ACT) Shares 26% But It Can Do More

Why AlzChem Group AG (ETR:ACT) Could Be Worth Watching

Nov 01
Why AlzChem Group AG (ETR:ACT) Could Be Worth Watching

Is There An Opportunity With AlzChem Group AG's (ETR:ACT) 42% Undervaluation?

Oct 12
Is There An Opportunity With AlzChem Group AG's (ETR:ACT) 42% Undervaluation?

AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

May 06
AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment

May 05
AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment

AlzChem Group (ETR:ACT) Will Pay A Larger Dividend Than Last Year At €1.05

Apr 05
AlzChem Group (ETR:ACT) Will Pay A Larger Dividend Than Last Year At €1.05

AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

Mar 04
AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year

Apr 24
AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year

AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00

Mar 29
AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00

AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00

Feb 27
AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00

AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Nov 23
AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?

Jun 10
Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?

At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?

Apr 07
At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?

AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?

Mar 23
AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?

AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price

Mar 10
AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price

Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 24
Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)

Feb 11
Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)

Update: AlzChem Group (ETR:ACT) Stock Gained 13% In The Last Year

Aug 07
Update: AlzChem Group (ETR:ACT) Stock Gained 13% In The Last Year

Is Now An Opportune Moment To Examine AlzChem Group AG (ETR:ACT)?

Jul 20
Is Now An Opportune Moment To Examine AlzChem Group AG (ETR:ACT)?

Does This Valuation Of AlzChem Group AG (ETR:ACT) Imply Investors Are Overpaying?

Jul 03
Does This Valuation Of AlzChem Group AG (ETR:ACT) Imply Investors Are Overpaying?

業績と収益の成長予測

XTRA:ACT - アナリストの将来予測と過去の財務データ ( )EUR Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20266295123734
12/31/20255954616674
12/31/20245664231684
3/31/2024543397596N/A
12/31/2023546355273N/A
9/30/2023538303055N/A
6/30/2023559282853N/A
3/31/202357430-1012N/A
12/31/202255030-33-4N/A
9/30/202253429-254N/A
6/30/202248728-280N/A
3/31/202245427329N/A
12/31/2021429281443N/A
9/30/2021420271140N/A
6/30/2021406263463N/A
3/31/2021397231448N/A
12/31/2020386202049N/A
9/30/2020370161052N/A
6/30/2020389171153N/A
3/31/2020387172054N/A
12/31/201938518244N/A
9/30/201938919242N/A
6/30/201938018-1822N/A
3/31/201938020-2033N/A
12/31/201838323-535N/A
9/30/2018380221224N/A
6/30/201839832-131N/A
3/31/201836421223N/A
12/31/201736120N/A31N/A
9/30/201735622N/A31N/A
12/31/201633315N/A33N/A
9/30/201633112N/A39N/A
12/31/201532915N/A30N/A
12/31/201429814N/A18N/A
12/31/201330217N/A16N/A

アナリストによる今後の成長予測

収入対貯蓄率: ACTの予測収益成長率 (年間9.4% ) は 貯蓄率 ( 0.7% ) を上回っています。

収益対市場: ACTの収益 ( 9.4% ) German市場 ( 18.6% ) よりも低い成長が予測されています。

高成長収益: ACTの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: ACTの収益 ( 4.8% ) German市場 ( 5.1% ) よりも低い成長が予測されています。

高い収益成長: ACTの収益 ( 4.8% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: ACTの 自己資本利益率 は、3年後には高くなると予測されています ( 21.2 %)


成長企業の発掘